Literature DB >> 1721283

Effect of FK 506 chronic administration on bromosulphthalein hepatic excretion in rats.

H Farghali1, M Sakr, A Gasbarrini, R Venkataramanan, J Gavaler, T E Starzl, D H Van Thiel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1721283      PMCID： PMC2965618     

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  3 in total

1.  Toxicology of FK-506 in the Lewis rat.

Authors:  M A Nalesnik; S Todo; N Murase; S Gryzan; P H Lee; L Makowka; T E Starzl
Journal:  Transplant Proc       Date:  1987-10       Impact factor: 1.066

2.  FK 506 ameliorates the hepatic injury associated with ischemia.

Authors:  M F Sakr; T I Hassanein; G M Zetti; D H Van Thiel
Journal:  Life Sci       Date:  1990       Impact factor: 5.037

3.  FK 506 ameliorates the hepatic injury associated with ischemia and reperfusion in rats.

Authors:  M F Sakr; G M Zetti; T I Hassanein; H Farghali; M A Nalesnik; J S Gavaler; T E Starzl; D H Van Thiel
Journal:  Hepatology       Date:  1991-05       Impact factor: 17.425
  3 in total
  3 in total

Review 1.  Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation.

Authors:  D H Peters; A Fitton; G L Plosker; D Faulds
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

Review 2.  Clinical pharmacokinetics of tacrolimus.

Authors:  R Venkataramanan; A Swaminathan; T Prasad; A Jain; S Zuckerman; V Warty; J McMichael; J Lever; G Burckart; T Starzl
Journal:  Clin Pharmacokinet       Date:  1995-12       Impact factor: 6.447

Review 3.  Mechanisms of clinically relevant drug interactions associated with tacrolimus.

Authors:  Uwe Christians; Wolfgang Jacobsen; Leslie Z Benet; Alfonso Lampen
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.